These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 3138921)
21. T3 augmentation of a tricyclic antidepressant in a patient receiving T4 maintenance therapy. Cooke RG Am J Psychiatry; 1990 Feb; 147(2):255. PubMed ID: 2301670 [No Abstract] [Full Text] [Related]
22. Triiodothyronine potentiation of fluoxetine in depressed patients. Joffe RT Can J Psychiatry; 1992 Feb; 37(1):48-50. PubMed ID: 1551045 [TBL] [Abstract][Full Text] [Related]
23. Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Altshuler LL; Bauer M; Frye MA; Gitlin MJ; Mintz J; Szuba MP; Leight KL; Whybrow PC Am J Psychiatry; 2001 Oct; 158(10):1617-22. PubMed ID: 11578993 [TBL] [Abstract][Full Text] [Related]
24. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Goodwin FK; Prange AJ; Post RM; Muscettola G; Lipton MA Am J Psychiatry; 1982 Jan; 139(1):34-8. PubMed ID: 7055275 [TBL] [Abstract][Full Text] [Related]
26. Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. Price LH; Conwell Y; Nelson JC Am J Psychiatry; 1983 Mar; 140(3):318-22. PubMed ID: 6131612 [TBL] [Abstract][Full Text] [Related]
27. A lithium-tricyclic combination for treatment of depression. Pande AD; Max P Am J Psychiatry; 1985 Oct; 142(10):1228-9. PubMed ID: 3929631 [No Abstract] [Full Text] [Related]
28. Questions about L-triiodothyronine and depression. Goodwin FK; Prange A Am J Psychiatry; 1982 Jul; 139(7):966. PubMed ID: 7091417 [No Abstract] [Full Text] [Related]
29. The management of resistant depression. Levine S Acta Psychiatr Belg; 1986; 86(2):141-51. PubMed ID: 3088916 [TBL] [Abstract][Full Text] [Related]
30. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Aronson R; Offman HJ; Joffe RT; Naylor CD Arch Gen Psychiatry; 1996 Sep; 53(9):842-8. PubMed ID: 8792761 [TBL] [Abstract][Full Text] [Related]
31. Psychopharmacologic treatment of depression. Extein I; Gold MS; Pottash AL Psychiatr Clin North Am; 1984 Sep; 7(3):503-17. PubMed ID: 6148743 [TBL] [Abstract][Full Text] [Related]
32. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate. Meltzer HY; Lowy M; Robertson A; Goodnick P; Perline R Arch Gen Psychiatry; 1984 Apr; 41(4):391-7. PubMed ID: 6422900 [TBL] [Abstract][Full Text] [Related]
33. Research overview of drug therapy in recurrent and chronic depression. Prien RF Adv Biochem Psychopharmacol; 1985; 40():121-30. PubMed ID: 3895838 [No Abstract] [Full Text] [Related]
34. The psychopharmacologic treatment of major depression. Stoudemire A J Med Assoc Ga; 1988 Nov; 77(11):821-4. PubMed ID: 3142958 [No Abstract] [Full Text] [Related]
37. Lack of advantage for imipramine combined with lithium versus imipramine alone in the treatment of major depression--a double-blind controlled study. Shahal B; Piel E; Mecz L; Kremer I; Klein E Biol Psychiatry; 1996 Dec; 40(11):1181-3. PubMed ID: 8931923 [No Abstract] [Full Text] [Related]